文献速递乳腺MR乳腺X线

影像学一致的良性MRI引导真空辅助乳腺活检可能无需MRI随访

Imaging-Concordant Benign MRI-Guided Vacuum-Assisted Breast Biopsy May Not Warrant MRI Follow-Up.
PubMed 文献 · AJR Am J Roentgenol · 2017-01-31

回顾性分析2007-2012年169个MRI引导9G真空辅助活检且影像学与良性组织学一致的乳腺病灶,计算假漏诊率为0.6%(4/169),其中1例为活检部位1cm的浸润性导管癌,3例位于活检部位4cm以外;作者认为影像学一致的良性活检结果可能无需MRI随访。

要点

  • 影像学与良性组织学一致的MRI引导VAB假漏诊率为0.6%(4/169)。
  • 4例后续恶性肿瘤中仅1例(0.6%)位于活检部位1cm处,3例距活检部位≥4cm。
  • 作者认为影像学一致的良性MRI引导VAB结果可能无需MRI随访。

核心结论

  • 乳腺MRI引导VAB的假漏诊率低,影像学与良性组织病理学一致的病灶可能无需MRI随访。

研究设计与样本

  • 回顾性研究,纳入2007-2012年接受9G乳腺MRI引导VAB、影像学与良性组织病理学一致且有手术或至少2年影像随访的169个病灶。

关键影像表现/征象

  • 135个病灶仅影像随访:48个仅乳腺X线摄影(范围26-86个月,中位52个月),87个乳腺X线摄影(范围17-107个月,中位52个月)联合MRI(范围5-95个月,中位35个月)。
  • 34个病灶有手术对照,未发现影像-手术不一致。
  • 同侧乳腺后续诊断4例恶性肿瘤:1例(0.6%)为距MRI引导VAB部位1cm的浸润性导管癌,于VAB后24个月经乳腺X线摄影检出。
  • 另3例距MRI引导VAB部位4cm或以上:1例导管原位癌于VAB后12个月经乳腺X线摄影检出,1例导管原位癌于VAB后24个月经MRI检出,1例Paget病于VAB后32个月经体格检查检出。

诊断标准与关键数值

  • 假漏诊率=1-阴性预测值=[假阴性数/阴性数],本组为0.6%(4/169)。

临床应用与阅片要点

  • 作者认为影像学与良性组织病理学一致的MRI引导VAB病灶可能无需MRI随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The follow-up of breast lesions with imaging-concordant benign histopathology results on MRI-guided vacuum-assisted biopsy (VAB) is not currently standardized. We determined the false omission rate of breast MRI-guided VAB with benign histopathology (negative results) to assess whether breast MRI follow-up is needed.

MATERIALS AND METHODS: The medical records of patients who underwent 9-gauge breast MRI-guided VAB during 2007-2012 were reviewed retrospectively. Lesions with imaging-concordant benign histopathology results from MRI-guided VAB and surgery or 2 years or more of imaging follow-up were included. The false omission rate (1 - negative predictive value; [number of false-negative results / number of negative results]) of MRI-guided VAB was calculated.

RESULTS: One hundred sixty-nine lesions were included, and 135 had only imaging follow-up (mammography follow-up: range, 17-107 months [median, 52 months]; MRI follow-up: range, 5-95 months [median, 35 months]). Of the 135 lesions with only imaging follow-up, 48 had mammography only (range, 26-86 months; median, 52 months), and 87 had mammography (range, 17-107 months; median, 52 months) and MRI (range, 5-95 months; median, 35 months). Thirty-four lesions had surgical correlation, and there were no cases of imaging-surgical discordance. Four malignancies were later diagnosed in the same breast in which MRI-guided VAB had been performed. One (0.6%) malignancy was invasive ductal carcinoma at 1 cm from the MRI-guided VAB site; it was mammographically detected 24 months after MRI-guided VAB. The other three malignancies developed 4 cm or more from the site of MRI-guided VAB: one ductal carcinoma in situ (DCIS) detected on mammography 12 months after MRI-guided VAB, one DCIS detected on MRI 24 months after MRI-guided VAB, and one Paget disease lesion detected at physical examination 32 months after MRI-guided VAB.

CONCLUSION: Breast MRI-guided VAB has a low false omission rate. MRI follow-up of lesions with concordant benign MRI-guided VAB histopathology results may not be warranted.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Huang ML, Speer M, Dogan BE, et al. Imaging-Concordant Benign MRI-Guided Vacuum-Assisted Breast Biopsy May Not Warrant MRI Follow-Up. AJR Am J Roentgenol. 2017. PMID: 28140609. doi:10.2214/AJR.16.16576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。